Richard A. Brigandi

936 total citations
17 papers, 501 citations indexed

About

Richard A. Brigandi is a scholar working on Parasitology, Surgery and Small Animals. According to data from OpenAlex, Richard A. Brigandi has authored 17 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Parasitology, 4 papers in Surgery and 4 papers in Small Animals. Recurrent topics in Richard A. Brigandi's work include Parasites and Host Interactions (6 papers), Helminth infection and control (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Richard A. Brigandi is often cited by papers focused on Parasites and Host Interactions (6 papers), Helminth infection and control (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Richard A. Brigandi collaborates with scholars based in United States, United Kingdom and Australia. Richard A. Brigandi's co-authors include Harris L. Rotman, Thomas J. Nolan, Wiboonchai Yutanawiboonchai, Gerhard A. Schad, David Abraham, David Abraham, Ofra Leon, Sung‐Soo Yoon, Andrew Spencer and Joanna Opalinska and has published in prestigious journals such as Blood, Gastroenterology and British Journal of Anaesthesia.

In The Last Decade

Richard A. Brigandi

17 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard A. Brigandi United States 11 216 134 94 89 80 17 501
Young Mee Bae South Korea 16 259 1.2× 121 0.9× 165 1.8× 118 1.3× 44 0.6× 30 669
Luciana I. Gomes Brazil 17 257 1.2× 104 0.8× 151 1.6× 100 1.1× 192 2.4× 38 749
David Carey United States 9 200 0.9× 63 0.5× 43 0.5× 37 0.4× 32 0.4× 12 380
A J Dessein France 8 278 1.3× 51 0.4× 108 1.1× 64 0.7× 17 0.2× 9 491
Lisi Huang China 10 199 0.9× 104 0.8× 52 0.6× 102 1.1× 18 0.2× 21 381
Julie Osborne United Kingdom 14 278 1.3× 62 0.5× 186 2.0× 68 0.8× 181 2.3× 16 835
Jifeng Zhu China 15 260 1.2× 215 1.6× 207 2.2× 22 0.2× 94 1.2× 34 668
Lucas Kraemer Brazil 13 165 0.8× 84 0.6× 101 1.1× 76 0.9× 42 0.5× 29 402
Aloukick Kumar Singh India 14 212 1.0× 74 0.6× 65 0.7× 14 0.2× 31 0.4× 28 579
Jonathan M. Swartz United States 10 82 0.4× 89 0.7× 72 0.8× 20 0.2× 24 0.3× 15 309

Countries citing papers authored by Richard A. Brigandi

Since Specialization
Citations

This map shows the geographic impact of Richard A. Brigandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Brigandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Brigandi more than expected).

Fields of papers citing papers by Richard A. Brigandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. Brigandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Brigandi. The network helps show where Richard A. Brigandi may publish in the future.

Co-authorship network of co-authors of Richard A. Brigandi

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. Brigandi. A scholar is included among the top collaborators of Richard A. Brigandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. Brigandi. Richard A. Brigandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Klarenbeek, Naomi B., Martijn B. A. van Doorn, Robert Rißmann, et al.. (2023). Intradermal substance P as a challenge agent in healthy individuals. Clinical and Translational Science. 16(10). 1856–1865. 2 indexed citations
2.
Brigandi, Richard A., et al.. (2019). A population analysis of the DGAT1 inhibitor GSK3008356 and its effect on endogenous and meal‐induced triglyceride turnover in healthy subjects. Fundamental and Clinical Pharmacology. 33(5). 567–580. 5 indexed citations
3.
Zhu, Xinyi, et al.. (2019). First‐in‐Human Pharmacokinetics and Safety Study of GSK3008356, a Selective DGAT1 Inhibitor, in Healthy Volunteers. Clinical Pharmacology in Drug Development. 8(8). 1088–1099. 5 indexed citations
4.
Brigandi, Richard A., et al.. (2019). A Phase 1 Randomized, Placebo‐Controlled Trial With a Topical Inhibitor of Stearoyl‐Coenzyme A Desaturase 1 Under Occluded and Nonoccluded Conditions. Clinical Pharmacology in Drug Development. 8(3). 270–280. 9 indexed citations
5.
Kranke, Peter, John Paul Thompson, Leopold Eberhart, et al.. (2014). Comparison of vestipitant with ondansetron for the treatment of breakthrough postoperative nausea and vomiting after failed prophylaxis with ondansetron. British Journal of Anaesthesia. 114(3). 423–429. 13 indexed citations
6.
Brigandi, Richard A., et al.. (2014). Intravenous pharmacokinetics, local tolerability, and hemolysis of an SBE7‐β‐cyclodextrin formulation of the neurokinin‐1 receptor antagonist vestipitant. Clinical Pharmacology in Drug Development. 4(2). 130–136. 6 indexed citations
7.
Spencer, Andrew, Sung‐Soo Yoon, Simon J. Harrison, et al.. (2014). The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma. Blood. 124(14). 2190–2195. 108 indexed citations
8.
Spencer, Andrew, Sung‐Soo Yoon, Simon J. Harrison, et al.. (2011). Novel AKT Inhibitor GSK2110183 Shows Favorable Safety, Pharmacokinetics, and Clinical Activity in Multiple Myeloma. Preliminary Results From a Phase I First-Time-In-Human Study. Blood. 118(21). 1856–1856. 15 indexed citations
9.
McHutchison, John G., Zachary Goodman, Keyur Patel, et al.. (2009). Farglitazar Lacks Antifibrotic Activity in Patients With Chronic Hepatitis C Infection. Gastroenterology. 138(4). 1365–1373.e2. 66 indexed citations
10.
McLaughlin, Megan, Andrew I. Bayliffe, Thomas L. Hunt, et al.. (2009). A Multi-Targeted Receptor Tyrosine Kinase Inhibitor for the Treatment of Neovascular AMD: Results of a Healthy Volunteer Safety and Tolerability Study of Pazopanib Eye Drops. 50(13). 5008–5008. 1 indexed citations
11.
Brigandi, Richard A., Harris L. Rotman, Olivier Léon, et al.. (1998). Strongyloides stercoralis Host-Adapted Third-Stage Larvae Are the Target of Eosinophil-Associated Immune-Mediated Killing in Mice. Journal of Parasitology. 84(2). 440–440. 11 indexed citations
12.
Brigandi, Richard A., Harris L. Rotman, Thomas J. Nolan, G. A. Schad, & David Abraham. (1997). Chronicity in Strongyloides stercoralis Infections: Dichotomy of the Protective Immune Response to Infective and Autoinfective Larvae in a Mouse Model. American Journal of Tropical Medicine and Hygiene. 56(6). 640–646. 26 indexed citations
13.
Rotman, Harris L., Wiboonchai Yutanawiboonchai, Richard A. Brigandi, et al.. (1996). Strongyloides stercoralis:Eosinophil-Dependent Immune-Mediated Killing of Third Stage Larvae in BALB/cByJ Mice. Experimental Parasitology. 82(3). 267–278. 87 indexed citations
14.
Brigandi, Richard A., Harris L. Rotman, Wiboonchai Yutanawiboonchai, et al.. (1996). Strongyloides stercoralis:Role of Antibody and Complement in Immunity to the Third Stage Larvae in BALB/cByJ Mice. Experimental Parasitology. 82(3). 279–289. 51 indexed citations
15.
Yutanawiboonchai, Wiboonchai, Richard A. Brigandi, Harris L. Rotman, & David Abraham. (1996). Structural and molecular specificity of antibody responses in mice immune to third stage larvae of Onchocerca volvulus. Parasite Immunology. 18(2). 95–102. 10 indexed citations
16.
Rotman, Harris L., Wiboonchai Yutanawiboonchai, Richard A. Brigandi, et al.. (1995). Strongyloides stercoralis: Complete Life Cycle in SCID Mice. Experimental Parasitology. 81(1). 136–139. 16 indexed citations
17.
Abraham, David, Harris L. Rotman, Wiboonchai Yutanawiboonchai, et al.. (1995). Strongyloides stercoralis: Protective Immunity to Third-Stage Larvae in BALB/cByJ Mice. Experimental Parasitology. 80(2). 297–307. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Young Mee Bae Breakdown of academic impact, for papers by Luciana I. Gomes Breakdown of academic impact, for papers by David Carey Breakdown of academic impact, for papers by A J Dessein Breakdown of academic impact, for papers by Lisi Huang Breakdown of academic impact, for papers by Julie Osborne Breakdown of academic impact, for papers by Jifeng Zhu Breakdown of academic impact, for papers by Lucas Kraemer Breakdown of academic impact, for papers by Aloukick Kumar Singh Breakdown of academic impact, for papers by Jonathan M. Swartz
Rankless by CCL
2026